Definitive Contract W911NF18C0087

Award Date 9/27/18
Potential Completion Date 11/29/20
Potential Value $999K
Funding Federal Agency
US Special Operations Command
Contracting Federal Agency
ACC Aberdeen Proving Ground
Ultimate Awardee
Not listed
Set-Aside Type
Total Small Business
Federal Contract Vehicle
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Potomac, MD 20850, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
5
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
SBIR Program Phase II Action
Primary Consortia Member
Not listed
Similar Awards
This is a definitive contract awarded by the Defense Health Agency (DHA), a defense agency, to Cellphire, Inc., a small business biotechnology company, for the development of a Food and Drug Administration (FDA)-licensed cryopreserved platelet (CPP) product for the U.S. Military. The contract has a ceiling value of $63,947,008.00 and is a cost-plus-fixed-fee type contract. The purpose of the contract is to conduct all activities necessary to successfully develop an FDA-licensed CPP product,...
This federal contract award, with ID H9240521C0002, was made by the U.S. Special Operations Command (USSOCOM) to Mantel Technologies, Inc., a small business manufacturer located in Fort Collins, Colorado. The $1,912,484.00 contract is a Phase II Small Business Innovation Research (SBIR) award for the development of a "Freeze Dried Plasma for Canines" prototype deliverable. This SBIR contract is focused on advancing canine-related technologies, which is a key area of interest for...
<p>This is a Phase I Small Business Innovation Research (SBIR) contract awarded by the Defense Health Agency (DHA) to Desicorp, Inc. for the development of a thermally stable whole blood product for transfusion. The contract has a firm fixed price of $249,957.36 and a completion date of January 17, 2021. As a Phase I SBIR award, this contract is focused on the initial research and feasibility exploration of the proposed technology. The contract was set aside for small businesses.</p>
<p>This is a $2,751,772.06 cost-plus-fixed-fee definitive contract awarded by the Defense Health Agency (DHA) to Bodevet, Inc. for a clinical trial in support of trauma indications for lyophilized canine blood products. The contract has an ultimate completion date of July 31, 2024 and was awarded on May 1, 2020. This contract is not set aside for any specific business type. The place of performance is Potomac, MD. Bodevet, Inc. is a self-certified small disadvantaged business.</p>
This is a $1,752,422.00 Cost Plus Fixed Fee contract awarded by the United States Special Operations Command (USSOCOM) to Virtech Bio Inc., a self-certified small disadvantaged business. The contract is for the SBIR Phase II development of a prototype to enhance canine performance. It is set aside for total small business concerns. The contract has a completion date of December 11, 2023 and was awarded on December 10, 2018. The National Interest Action Code indicates this contract is...
This is a $999,964.00 Firm Fixed Price Definitive Contract awarded by the Defense Logistics Agency Troop Support to AA Plasma LLC, a small business research and development company. The contract is for basic research services under the SBIR Program Phase II, with a completion date of September 5, 2021. AA Plasma LLC has previously provided services such as advanced oxidation research, mechanical and electrical engineering, gas phase and surface diagnostics, durable coating deposition, and SBIR...
This is a Small Business Innovation Research (SBIR) Program Phase I contract awarded by the Air Force Research Laboratory (AFRL) to Bluegrass Embedded Design LLC, doing business as Faradine Systems. The contract is for the development of the RESCUEPACK WHOLE BLOOD MANAGEMENT SYSTEM, which is designed to optimize the storage and transport of two units of whole blood. The contract has a firm fixed price of $74,927.00 and a completion date of August 15, 2024. The contract is set aside for small...
This is a $150,000.00 firm fixed price contract awarded by the U.S. Army Medical Command (MEDCOM) to Sylvatica Biotech Inc., a minority-owned small business, under the Small Business Innovation Research (SBIR) Program Phase I. The contract provides funding for research and development of a novel cryostasis cocktail and protocol to enable high subzero banking of human organs, building on prior SBIR Phase I work. The contract has a completion date of April 29, 2016 and is designated as a total...
This federal contract award was issued by the Defense Health Agency (DHA) to Hybrid Plastics, Incorporated, a for-profit manufacturer, under the Small Business Innovation Research (SBIR) Program Phase II. The contract, valued at $999,997.59, is for the development of a &quot;Hemostatic Agent&quot; under the DHA PHASE II SBIR H2-0265 project. The contract is a Definitive Contract with a Cost Plus Fixed Fee pricing type, and the period of performance is from the award date of September 15, 2017...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Altitude Technologies Inc., doing business as Chinook Medical Gear. The $1,844.16 fixed-price delivery order is for the provision of 4,564,233,872 single blood-pack units with 450ML CPD. The contract has an ultimate completion date of April 30, 2024 and does not utilize a set-aside. Altitude Technologies Inc. is an 8(a) certified small disadvantaged business and HUBZone firm...

This is a $998,717.00 firm fixed-price contract awarded by the United States Special Operations Command to Cellphire, Inc., a small business biotechnology company, to provide freeze-dried plasma for canines. The contract was set aside for total small business participation. Cellphire has past experience providing research, development, and manufacturing services for lyophilized canine plasma and cryopreserved human platelets through prime contracts with the Department of the Army and Defense Health Agency under the Small Business Innovation Research (SBIR) program. The company has also conducted research on using intrinsically disordered proteins and cosolutes to induce reversible biostasis in human blood through federal grants as a subawardee.

Generated 3/21/24, 7:49 PM